|
|
|
Volumn 6, Issue 1, 2005, Pages 99-107
|
|
PBT-1 Prana Biotechnology
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMYLOID BETA PROTEIN;
BATHOCUPROINE;
CHELATING AGENT;
CLIOQUINOL;
CYANOCOBALAMIN;
EDETIC ACID;
EGTAZIC ACID;
ETHYLENEDIAMINE;
FOLIC ACID;
PBT 1;
PLACEBO;
UNCLASSIFIED DRUG;
ALZHEIMER DISEASE;
BINDING AFFINITY;
CHELATION THERAPY;
CLINICAL TRIAL;
CONCENTRATION RESPONSE;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG PENETRATION;
DRUG SELECTIVITY;
DRUG SYNTHESIS;
DRUG TARGETING;
DRUG TOLERABILITY;
HUMAN;
NEUROTOXICITY;
NONHUMAN;
REVIEW;
SINGLE DRUG DOSE;
STRUCTURE ACTIVITY RELATION;
SUBACUTE MYELOOPTIC NEUROPATHY;
VACCINATION;
VISUAL DISORDER;
VITAMIN SUPPLEMENTATION;
ALZHEIMER DISEASE;
AMYLOID BETA-PROTEIN;
ANIMALS;
CLINICAL TRIALS;
CLIOQUINOL;
HUMANS;
|
|
EID: 12544255535
PISSN: 14724472
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (14)
|
|
References (0)
|
